Dogmatyl



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 75.0%
Depression 12.5%
Insomnia 12.5%
Hepatic Fibrosis 50.0%
Theft 50.0%
Secondary
Depression 31.4%
Drug Use For Unknown Indication 24.0%
Anxiety 6.0%
Insomnia 5.3%
Dissociative Disorder 4.6%
Emphysema 2.9%
Atrial Fibrillation 2.7%
Dementia 2.7%
Angina Pectoris 2.4%
Constipation 2.2%
Hypertension 2.1%
Schizophrenia 2.1%
Panic Disorder 2.0%
Anorexia 1.6%
Rheumatoid Arthritis 1.6%
Depressive Symptom 1.5%
Affect Lability 1.3%
Major Depression 1.3%
Cardiac Failure 1.2%
Chronic Hepatitis C 1.2%
Completed Suicide 11.2%
Vomiting 8.0%
Weight Increased 7.2%
Rhabdomyolysis 6.4%
Hepatic Function Abnormal 5.6%
Parkinsonism 5.6%
Persecutory Delusion 5.6%
Tonic Convulsion 5.6%
Neuroleptic Malignant Syndrome 4.8%
Stevens-johnson Syndrome 4.8%
Liver Disorder 4.0%
Pyrexia 4.0%
Somnolence 4.0%
Suicide Attempt 4.0%
Drug Rash With Eosinophilia And Systemic Symptoms 3.2%
Pancreatitis Acute 3.2%
Pregnancy 3.2%
Septic Shock 3.2%
Somnolence Neonatal 3.2%
Unresponsive To Stimuli 3.2%
Concomitant
Depression 20.6%
Drug Use For Unknown Indication 11.4%
Prophylaxis 9.8%
Insomnia 8.4%
Hypertension 8.1%
Hepatitis C 6.8%
Product Used For Unknown Indication 5.4%
Chronic Hepatitis C 4.8%
Constipation 4.0%
Rheumatoid Arthritis 3.6%
Schizophrenia 2.4%
Hyperlipidaemia 2.2%
Pain 1.9%
Gastritis 1.8%
Gastric Ulcer 1.7%
Osteoporosis 1.6%
Cancer Pain 1.5%
Rash 1.5%
Pancreatic Neuroendocrine Tumour 1.4%
Crohn's Disease 1.3%
White Blood Cell Count Decreased 9.8%
Tremor 7.0%
Interstitial Lung Disease 5.9%
Pneumonia 5.6%
Vomiting 5.6%
Liver Disorder 5.3%
Insomnia 5.0%
Suicidal Ideation 5.0%
Renal Impairment 4.8%
Rhabdomyolysis 4.8%
Anaemia 4.5%
Decreased Appetite 4.5%
Platelet Count Decreased 4.5%
Suicide Attempt 4.5%
Hepatic Function Abnormal 4.2%
Off Label Use 4.2%
Pyrexia 3.9%
Rash 3.9%
Renal Disorder 3.6%
Depression 3.4%
Interacting
Anxiety 30.8%
Depression 30.8%
Drug Use For Unknown Indication 15.4%
Initial Insomnia 15.4%
Insomnia 7.7%
Weight Decreased 50.0%
Liver Function Test Abnormal 25.0%
Neuroleptic Malignant Syndrome 25.0%